NLRP3-IN-12 is a specific inhibitor of the NLRP3 inflammasome that targets the NLRP3 protein to effectively reduce IL-1beta release, with an IC50 of 0.45 µM. This compound is utilized in the research of inflammatory bowel disease (IBD).
Molecular Weight:
518
Formula:
C27H32ClNO7
Target:
NOD-like Receptor (NLR)|||Others
T73034
* VAT and and shipping costs not included. Errors and price changes excepted
